Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia

被引：0
|
作者：
Claudia Stefanutti
机构：
[1] “Sapienza” University of Rome,Extracorporeal Therapeutic Techniques Unit, Lipid Clinic and Atherosclerosis Prevention Centre, Regional Centre (Lazio) for Rare Diseases, Immunohematology and Transfusion Medicine, Department of Molecular Medicine
[2] “Umberto I” Hospital,undefined
来源：
Current Atherosclerosis Reports | 2020年 / 22卷
关键词：
Homozygous familial hypercholesterolemia; Lomitapide; Cardiovascular disease; Lipoprotein apheresis; Drug therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The Role of Microsomal Triglyceride Transfer Protein Inhibitors in the Treatment of Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management
    Ahmad, Zahid
    Khera, Amit
    CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (01)
  • [42] Mipomersen and lomitapide: Two new drugs for the treatment of homozygous familial hypercholesterolemia
    Gouni-Berthold, Ioanna
    Berthold, Heiner K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2015, 18 : 28 - 34
  • [43] RESOLUTION OF PLANAR XANTHOMA IN A PATIENT WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LOMITAPIDE
    Underberg, James
    Schwartzbard, Arthur
    CLINICAL CARDIOLOGY, 2015, 38 : 11 - 11
  • [44] Lomitapide for the Management of Homozygous Familial Hypercholesterolemia (vol 15, pg 109, 2014)
    deGoma, Emil M.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2014, 15 (03) : 281 - 282
  • [45] Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide
    van Lennep, Jeanine Roeters
    Averna, Maurizio
    Alonso, Rodrigo
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (04) : 607 - 617
  • [46] The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis
    Leipold, Robert
    Raal, Frederick
    Ishak, Jack
    Hovingh, Kees
    Phillips, Helen
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (17) : 1843 - 1850
  • [47] Homozygous familial hypercholesterolemia. First case in Spain treated with lomitapide, an inhibitor of the synthesis of lipoproteins with apolipoprotein B
    Alonso, Rodrigo
    Mata, Pedro
    Alonso y Gregorio, Moises
    de Andres, Raimundo
    MEDICINA CLINICA, 2015, 145 (05): : 229 - 230
  • [48] Lomitapide for homozygous familial hypercholesterolaemia
    Raal, Frederick J.
    LANCET, 2013, 381 (9860): : 7 - 8
  • [49] Lomitapide and Mipomersen—Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis
    Dirk J. Blom
    Frederick J. Raal
    Raul D. Santos
    A. David Marais
    Current Atherosclerosis Reports, 2019, 21
  • [50] LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design
    Blom, Dirk J.
    Fayad, Zahi A.
    Kastelein, John J. P.
    Larrey, Dominique
    Makris, Lukas
    Schwamlein, Charles
    Bloeden, LeAnne
    Underberg, James
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (02) : 273 - 282
12345